Target intelligence / Profile preview

DEAD-box RNA helicase (DDX helicases acting as innate immune receptors) (DDX helicases)

Target
DDX helicases
Molecular classification
Enzyme, Receptor
01

Overview

DEAD-box (DDX) RNA helicases are a family of multifunctional enzymes characterized by a conserved helicase core with RecA-like domains that bind and unwind RNA structures in an ATP-dependent manner, enabling roles in RNA metabolism, genome stability, and innate immunity. Several members, such as DDX41, act as cytosolic sensors for foreign nucleic acids like viral DNA, bacterial cyclic dinucleotides, or self-DNA/RNA hybrids (R-loops), activating the STING-TBK1-IRF3 pathway to induce type I interferon responses and anti-pathogen defenses. DDX41 exemplifies this by recognizing cytosolic DNA independently of cGAS, binding STING to trigger IFN production during infections like HSV or adenovirus, while also resolving R-loops to prevent replication stress and maintain hematopoietic stem cell function. Beyond immunity, DDX helicases like DDX1, DDX5, and DDX21 regulate splicing, DNA repair, and ribosome biogenesis, with deficiencies causing DNA damage or aberrant transcripts. In disease, DDX41 loss-of-function mutations are linked to myeloid malignancies (MDS/AML), promoting inflammation, genome instability, and disrupted erythropoiesis via elevated R-loops and cGAS-STING signaling. No direct drugs target these helicases clinically, but their roles highlight therapeutic potential in modulating innate immunity or cancer, balanced against risks like hematopoietic toxicity.

Other names
DExD/H-box helicasesDEAD/H-box RNA helicasesRNA helicases (innate immune sensors)
02

Biological functions

Innate immune responseSignal transductionGenome stabilityRNA metabolism (splicing, ribosome biogenesis)Hematopoiesis
03

Disease associations

Cancer (myelodysplastic syndrome/acute myeloid leukemia)Infection (viral, bacterial)Inflammation
04

Safety considerations

Disruption of R-loop homeostasis leading to genome instabilityexcessive inflammation via cGAS-STING pathwayimpaired hematopoiesis (e.g., erythroid progenitor defects)potential for replication stress or splicing aberrations with inhibition
05

Biomarkers

DDX41 mutations (e.g., loss-of-function in familial/sporadic MDS/AML for patient stratification)

Beyond the preview

Go deeper on DEAD-box RNA helicase (DDX helicases acting as innate immune receptors) (DDX helicases).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAD-box RNA helicase (DDX helicases acting as innate immune receptors) (DDX helicases).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call